Fluoroquinolones and isoniazid resistant TB: implications for the 2018 WHO guidance.

2019
https://researcherprofiles.org/profile/62675857
31371444
Stagg HR, Bothamley GH, Davidson JA, Kunst H, Lalor MK, Lipman MC, Loutet MG, Lozewicz S, Mohiyuddin T, Abbara A, Alexander E, Booth H, Creer DD, Harris RJ, Kon OM, Loebinger MR, McHugh TD, Milburn HJ, Palchaudhuri P, Phillips PPJ, Schmok E, Taylor L, Abubakar I, Baker LV, Barrett JC, Burgess H, Cosgrove C, Dunleavy A, Francis M, Gupta U, Hamid S, Haselden BM, Holden E, Kahr V, Lynn W, Perrin FM, Rahman A, Soobratty MR